Fdabaa-17-00123 a preclinical mouse model of acinetobacter baumannii infection for antibacterial development

Ended Definitive Contract Awarded Last action

Contract number
HHSF223201710199C
Awardee
Awarding agency
Obligated
$2,249,508

Award facts

Opportunity
  • FDABAA1700123N Solicitation number
Contract value 100% obligated
$2,249,507.99 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Negotiated Proposal / Quote
Pricing
Cost No Fee
Place of performance
Los Angeles, CA 90033, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00008 -$304,418
Other Administrative Action P00007 $0
Supplemental Agreement for work within scope P00006 $0
Change Order P00005 $0
Change Order P00004 $332,356
Other Administrative Action P00003 $0
Change Order P00002 $0
Other Administrative Action 1 $0
Original award $2,221,570

About this award

This is a definitive contract awarded by the Department of Health and Human Services Food and Drug Administration to the University of Southern California (USC) with a potential value of $2,249,507.99. The contract is for a preclinical mouse model of Acinetobacter baumannii infection to support antibacterial drug development. USC is the prime contractor, and Case Western Reserve University and the University of Florida are major subcontractors supporting this research effort. The contract does not utilize any set-aside designation. USC has a history of providing a variety of goods and services to federal agencies through prime and subcontracts, including research activities in areas such as artificial intelligence, modeling, and analytics. Case Western Reserve University and the University of Florida also have extensive experience supporting federal research and development efforts across biomedical, scientific, and technical domains through grants and contracts.

Quick answers

Who was awarded contract HHSF223201710199C?

HHSF223201710199C was awarded to University Of Southern California by Food and Drug Administration (Department of Health and Human Services) on September 25, 2017.

How much is contract HHSF223201710199C worth?

The government has obligated $2,249,508 on HHSF223201710199C.

Was contract HHSF223201710199C competed?

The extent of competition for HHSF223201710199C was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award